NCT00448032View on ClinicalTrials.gov

Study Evaluating Multiple Oral Doses of PPM-204 in Healthy Japanese Male Subjects

PHASE1CompletedINTERVENTIONAL

Timeline

Start Date

November 30, 2006

Study Completion Date

March 31, 2007

Conditions

Diabetes Mellitus

Interventions

DRUG

PPM-204

Trial Locations (1)

171-0014

Tokyo

All Listed Sponsors

lead

Wyeth is now a wholly owned subsidiary of Pfizer

INDUSTRY

NCT00448032 - Study Evaluating Multiple Oral Doses of PPM-204 in Healthy Japanese Male Subjects | Biotech Hunter | Biotech Hunter